Citations

Clear

3485 citation(s) found for "Sy, Sarah".

A Polymeric Fastener Can Easily Functionalize Liposome Surfaces with Gadolinium for Enhanced Magnetic Resonance Imaging
Smith, Cartney E., Shkumatov, Artem, Withers, Sarah G., Yang, Binxia , Glockner, James F., Roy, Edward J. , Wong, Chun‐Ho , Zimmerman, Steven C. , Kong, Hyunjoon , Misra, Sanjay , Misra, Sanjay , Kong, Hyunjoon , Misra, Sanjay

Mayo Clinic

ACS Nano | October 1, 2013 | Volume: 7 | Issue: 11 | Pages: 9599-9610

10.1021/nn4026228 | PMID 24083377 Get It

Novel TRAF1‐ALK fusion identified by deep RNA sequencing of anaplastic large cell lymphoma
Vasmatzis, George , Asmann, Yan W. , Davila, Jaime , Middha, Sumit , Eckloff, Bruce W., Johnson, Sarah H. , Porcher, Julie C., Ansell, Stephen M. , Caride, Ariel J. , Feldman, Andrew L. , Davila, Jaime I

Mayo Clinic

Genes, Chromosomes and Cancer | September 2, 2013 | Volume: 52 | Issue: 11 | Pages: 1097-1102

10.1002/gcc.22104 | PMID 23999969 Get It

Chromosomal translocations leading to expression of abnormal fusion proteins play a major role in the pathogenesis of various hematologic malignancies. The recent development of high‐throughput, “deep” sequencing has allowed discovery of novel translocations leading to a rapid increase in understanding these diseases. Translocations involving the anaplastic lymphoma kinase (ALK) gene leading to ALK fusion proteins originally were discovered in anaplastic large cell lymphomas (ALCLs). Among ALCLs, NPM1‐ALK fusions are most common and lead to nuclear localization of the fusion protein. Here, we present a 50‐year‐old male with ALCL demonstrating cytoplasmic ALK immunoreactivity only, suggesting the presence of a non‐NPM1 fusion partner. We performed deep RNA sequencing of tumor tissue from this patient and identified a novel transcript fusing Exon 6 of TRAF1 to Exon 20 of ALK. The TRAF1‐ALK fusion transcript was confirmed at the mRNA level by Sanger sequencing and the fusion protein was visualized by Western blot. The discovery of this TRAF1‐ALK fusion expands the diversity of known ALK fusion partners and highlights the power of deep sequencing for fusion transcript discovery. © 2013 Wiley Periodicals, Inc.
Repairing Damaged Tendon and Muscle: Are Mesenchymal Stem cells and Scaffolds the Answer?
Davies, Benjamin M. , Baboldashti, Nasim Zargar, Hakimi, Osnat , Snelling, Sarah , Morrey, Mark E. , Mouthuy, Pierre‐Alexis , Price, Andrew James , Carr, Andrew Jonathan

Mayo Clinic

Regenerative Medicine | September 2, 2013 | Volume: 8 | Issue: 5 | Pages: 613-630

10.2217/rme.13.55 | PMID 23998754 Get It

Mouse model implicates GNB3 duplication in a childhood obesity syndrome
Goldlust, Ian S. , Hermetz, Karen , Catalano, Lisa M., Barfield, Richard , Cozad, Rebecca, Wynn, Grace M., Ozdemir, Alev Cagla, Conneely, Karen N. , Mullé, Jennifer G. , Dharamrup, Shikha, Hegde, Madhuri , Kim, Katherine H. , Angle, Brad, Colley, Alison, Thorland, Erik C., Ellison, Jay W., Ballif, Blake C., Shaffer, Lisa G. , Demmer, Laurie , Group, Unique Rare Chromosome Disorder Support, Rudd, M. Katharine , Searle, Beverly A., Wynn, Sarah , Webb, Amy , Rosenfeld, Jill A. , Group, Unique Rare Chromosome Disorder Support

Mayo Clinic

Proceedings of the National Academy of Sciences | August 26, 2013 | Volume: 110 | Issue: 37 | Pages: 14990-14994

10.1073/pnas.1305999110 | PMID 23980137 Get It

Significance We describe a genomic disorder that causes obesity, intellectual disability, and seizures. Children with this syndrome carry an unbalanced chromosome translocation that results in the duplication of over 100 genes, including G protein β3 ( GNB3 ). Although GNB3 polymorphisms have been associated with obesity, hypertension, and diabetes, the mechanism of GNB3 pathogenesis is unknown. We created a transgenic mouse model that carries a duplication of GNB3 , weighs significantly more than wild-type mice, and has excess abdominal fat. GNB3 is highly expressed in the brain and may be important for signaling related to satiety and/or metabolism.
A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis
Reese, Sarah E. , Archer, Kellie J. , Therneau, Terry M. , Atkinson, Elizabeth J. , Vachon, Celine M. , Kocher, Jean‐Pierre , Eckel‐Passow, Jeanette E. , Vachon, Celine M. , Andrade, Mariza de

Mayo Clinic

Bioinformatics | August 19, 2013 | Volume: 29 | Issue: 22 | Pages: 2877-2883

10.1093/bioinformatics/btt480 | PMID 23958724 Get It

Abstract Motivation: Batch effects are due to probe-specific systematic variation between groups of samples (batches) resulting from experimental features that are not of biological interest. Principal component analysis (PCA) is commonly used as a visual tool to determine whether batch effects exist after applying a global normalization method. However, PCA yields linear combinations of the variables that contribute maximum variance and thus will not necessarily detect batch effects if they are not the largest source of variability in the data. Results: We present an extension of PCA to quantify the existence of batch effects, called guided PCA (gPCA). We describe a test statistic that uses gPCA to test whether a batch effect exists. We apply our proposed test statistic derived using gPCA to simulated data and to two copy number variation case studies: the first study consisted of 614 samples from a breast cancer family study using Illumina Human 660 bead-chip arrays, whereas the second case study consisted of 703 samples from a family blood pressure study that used Affymetrix SNP Array 6.0. We demonstrate that our statistic has good statistical properties and is able to identify significant batch effects in two copy number variation case studies. Conclusion: We developed a new statistic that uses gPCA to identify whether batch effects exist in high-throughput genomic data. Although our examples pertain to copy number data, gPCA is general and can be used on other data types as well. Availability and implementation: The gPCA R package (Available via CRAN) provides functionality and data to perform the methods in this article. Contact: reesese@vcu.edu or eckel@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
The Integration of Studio Cycling into a Worksite Stress Management Programme
Clark, Matthew M. , Soyring, Jason E., Jenkins, Sarah M. , Daniels, Denise C., Berkland, Bridget E., Werneburg, Brooke L., Hagen, Philip T., Warren, Beth A., Olsen, Kerry D., López-Jiménez, Francisco

Mayo Clinic

Stress and Health | July 30, 2013 | Volume: 30 | Issue: 2 | Pages: 166-176

10.1002/smi.2514 | PMID 23897838 Get It

AbstractHigh stress is a prevalent problem in the worksite. To reduce stress, improve productivity, reduce absenteeism, and lower healthcare costs, many companies offer exercise classes or stress management programmes. Although physical activity is an important component of stress management, few worksites have integrated physical activity into their comprehensive stress reduction programmes. The purpose of this single‐arm pilot project was to examine the potential effectiveness of an integrated exercise (studio cycling) and cognitive–behavioural stress management programme. Eighty‐four adults, 75% female, mostly aged 40+ years, participated in an integrated 12‐week cycling studio and cognitive–behavioural stress management programme. Participants experienced a significant and clinically meaningful reduction on the Perceived Stress Scale (p < 0.01), rating of current stress level and confidence to manage stress at the programme's end and at a 1‐month follow‐up. Participants also reported having significantly improved overall health, improved nutritional habits, higher physical activity level, greater confidence in their ability to follow a healthy diet, higher spiritual well‐being, improved sleep, receiving more support for maintaining healthy living and improved quality of life at the completion of the 12‐week programme and 1‐month follow‐up. These findings provide further support for an integrated exercise and stress management programme. Copyright © 2013 John Wiley & Sons, Ltd.
Protein kinase D-mediated phosphorylation at Ser99 regulates localization of p21-activated kinase 4
Bastea, Ligia I. , Döppler, Heike, Durand, Nisha , Spratley, Samantha J., Störz, Peter , Pearce, Sarah E. , Bastea, Ligia

Mayo Clinic

Biochemical Journal | July 23, 2013 | Volume: 455 | Issue: 2 | Pages: 251-260

10.1042/bj20130281 | PMID 23841590 Get It

PAKs (p21-activated kinases) are effectors of RhoGTPases. PAK4 contributes to regulation of cofilin at the leading edge of migrating cells through activation of LIMK (Lin-11/Isl-1/Mec-3 kinase). PAK4 activity is regulated by an autoinhibitory domain that is released upon RhoGTPase binding as well as phosphorylation at Ser474 in the activation loop of the kinase domain. In the present study, we add another level of complexity to PAK4 regulation by showing that phosphorylation at Ser99 is required for its targeting to the leading edge. This phosphorylation is mediated by PKD1 (protein kinase D1). Phosphorylation of PAK4 at Ser99 also mediates binding to 14-3-3 protein, and is required for the formation of a PAK4–LIMK–PKD1 complex that regulates cofilin activity and directed cell migration.
Emergency Physicians Accurately Interpret Video Capsule Endoscopy Findings in Suspected Upper Gastrointestinal Hemorrhage: A Video Survey
Meltzer, Andrew C. , Pinchbeck, Carrie, Burnett, Sarah, Buhumaid, Rasha , Shah, Payal , Fleischer, David E., Gralnek, Ian M. , Ding, Ru , Meltzer, Andrew C

Mayo Clinic

Academic Emergency Medicine | July 16, 2013 | Volume: 20 | Issue: 7 | Pages: 711-715

10.1111/acem.12165 | PMID 23859585 Get It